Business Case Studies, Strategy Case Study, Mergers, Acquisitions, Alliances and Synergies

print page
Tell A Friend
Bookmark

Mergers, Acquisitions, Alliances and Synergies Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Amgen's Growth Strategies

Publication Year : 2004

Authors: B N Renuka Prasad, G Srikanth

Industry: Biotechnology

Region: USA

Case Code: MAA0017

Teaching Note: Not Available

Structured Assignment: Not Available


OR





Abstract:
Amgen, one of the world's leading biotechnology companies, had sales of $8.4 billion in 2003. Though the sales and profits of the company were higher than its competitors, it was lagging behind on the innovation front. Over the years the company grew with several mergers and acquisitions. It expected to achieve a turnover of $10 billion in 2004 and promised investors a 20% growth rate untill 2005.

Pedagogical Objectives:

  • To discuss Amgen's growth strategies and the way it intends to achieve its promised growth.

Keywords : Mergers, Acquisitions, Alliances Case Study;Amgen's growth strategies; Biotechnology industry; Research and development; Genentech, Chiron Corporation, Biogen; Patent expiries; American pharmaceutical industry; Roger M Perlmutter; Kevin W Sharer; United States Food and Drug Administration; Generic competition; Mergers and acquisitions; Immunex Corporation; Joint ventures; Epogen, Enbrel, Aranesp, Erythropoietin, Johnson and Johnson

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020 - 25 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap